Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 34.1
(-1.45%)
TWD 34.1
(-1.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 389.62 Million | 365.04 Million | 3.28 Billion | 11.5 Million | 1.12 Million | - |
| Cost of Revenue | 159.4 Million | 577.64 Million | 975.96 Million | 3.87 Million | - | 101.02 Million |
| Gross Profit | 230.22 Million | -212.6 Million | 2.3 Billion | 7.63 Million | 1.12 Million | -101.02 Million |
| Operating Expenses | 1.44 Billion | 1.32 Billion | 1.34 Billion | 771.51 Million | 605.03 Million | 466.33 Million |
| Selling, General and Administrative Expenses | 243.43 Million | 183.67 Million | 148.21 Million | 91.96 Million | 66.3 Million | 69.35 Million |
| Research and Development Expenses | 1.2 Billion | 1.13 Billion | 1.19 Billion | 679.55 Million | 538.73 Million | 396.97 Million |
| Other Expenses | - | 80.97 Million | 449.8 Million | 104.54 Million | 5.32 Million | 313 Thousand |
| Cost and Expenses | 1.6 Billion | 1.9 Billion | 2.31 Billion | 775.38 Million | 605.03 Million | 466.33 Million |
| Operating Income | -1.21 Billion | -1.44 Billion | 1.41 Billion | -657.86 Million | -598.59 Million | -466.33 Million |
| Interest Expense | 37.57 Million | 26.88 Million | 6.01 Million | 16.41 Million | 19.12 Million | 10.31 Million |
| Income Tax Expense | - | 26.88 Million | 6.01 Million | 16.41 Million | 19.12 Million | 313 Thousand |
| Earnings before Tax | -1.15 Billion | -1.47 Billion | 1.41 Billion | -674.28 Million | -617.71 Million | -476.34 Million |
| Net Income | -1.15 Billion | -1.5 Billion | 1.41 Billion | -690.69 Million | -636.84 Million | -476.34 Million |
| Earnings Per Share Basic | -3.53 | -4.64 | 4.47 | -2.48 | -2.69 | -2.14 |
| Earnings Per Share Diluted | -3.53 | -4.64 | 4.42 | -2.48 | -2.69 | -2.09 |
| Weighted Average Shares Outstanding | 328.56 Million | 323.47 Million | 315.53 Million | 278.27 Million | 236.57 Million | 222.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 328.31 Million | 323.47 Million | 319.1 Million | 278.27 Million | 236.57 Million | 228.26 Million |
| Gross Margin | 0.59 | -0.58 | 0.70 | 0.66 | 1.00 | - |
| EBIT Margin | -2.54 | -3.62 | 0.47 | -46.55 | -428.67 | - |
| Profit Margin | -2.98 | -4.11 | 0.43 | -60.02 | -568.61 | - |
| EBITDA | -991.09 Million | -1.31 Billion | 1.52 Billion | -535.6 Million | -480.1 Million | -365 Million |
| Earnings Before Tax Margin | -3.12 | -3.97 | 0.43 | -57.17 | -534.46 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 243 Million | 175.22 Million | 58.6 Million | 389.62 Million | 171.33 Million | 218.28 Million |
| Cost of Revenue | 103.74 Million | 48.87 Million | 34.2 Million | 168.47 Million | 54.48 Million | 106.95 Million |
| Gross Profit | 139.26 Million | 126.35 Million | 24.39 Million | 221.14 Million | 116.85 Million | 111.33 Million |
| Operating Expenses | 130.61 Million | 129.01 Million | 131.09 Million | 1.43 Billion | 662.67 Million | 198.31 Million |
| Selling, General and Administrative Expenses | - | 76.14 Million | 38 Million | - | 98.2 Million | 73.52 Million |
| Research and Development Expenses | - | 52.87 Million | 93.08 Million | - | 564.47 Million | 124.78 Million |
| Other Expenses | -130.61 Million | 4.68 Million | 33.97 Million | 8.28 Million | -43.3 Million | 26.71 Million |
| Cost and Expenses | 234.35 Million | 177.89 Million | 165.3 Million | 1.6 Billion | 717.16 Million | 305.26 Million |
| Operating Income | 8.65 Million | -2.66 Million | -106.7 Million | -1.21 Billion | -545.82 Million | -42.53 Million |
| Interest Expense | - | 5.22 Million | 9.4 Million | 37.57 Million | 9.42 Million | 9.49 Million |
| Income Tax Expense | - | - | 33.42 Million | 1.00 | 32.92 Million | 32.95 Million |
| Earnings before Tax | 1.5 Million | 13.55 Million | -73.41 Million | -1.15 Billion | -582.13 Million | -52.03 Million |
| Net Income | 1.5 Million | 13.55 Million | -73.41 Million | -1.15 Billion | -582.13 Million | -52.03 Million |
| Earnings Per Share Basic | 0.00 | 0.04 | -0.22 | - | -1.77 | -0.16 |
| Earnings Per Share Diluted | 0.00 | 0.04 | -0.22 | - | -1.77 | -0.16 |
| Weighted Average Shares Outstanding | - | 328.63 Million | 328.6 Million | 328.31 Million | 328.48 Million | 328.35 Million |
| Weighted Average Shares Outstanding (Diluted) | - | 328.69 Million | 328.6 Million | 328.31 Million | 328.48 Million | 328.35 Million |
| Gross Margin | 0.57 | 0.72 | 0.42 | 0.57 | 0.68 | 0.51 |
| EBIT Margin | 0.04 | 0.18 | -1.25 | - | -2.99 | -0.04 |
| Profit Margin | 0.01 | 0.08 | -1.25 | -2.98 | -3.40 | -0.24 |
| EBITDA | 8.65 Million | 31.28 Million | -73.23 Million | - | -512.85 Million | -9.61 Million |
| Earnings Before Tax Margin | 0.04 | -0.02 | -1.82 | -3.12 | -3.19 | -0.19 |
5226
HLOSF
BAY
GLCO
XAM
SWP